Gilead Sciences

Yahoo Finance • 2 days ago

Notable healthcare headlines for the week: Novo Nordisk, Bristol Myers Squibb and J&J in focus

Tom Werner Wall Street's major averages plummeted on Friday after U.S. President Donald Trump threatened higher tariffs to China, saying it had "become very hostile" sending letters to other countries wanting to "impose export controls."... Full story

Yahoo Finance • 7 days ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Plug Power Inc. 155,000,553 4.58 3.85 3.8888 +0.0788 Advanced Micro Devi... Full story

Yahoo Finance • 7 days ago

Gilead Sciences settles patent litigations related to Biktarvy

[Intellectual Property] stocknshares Gilead Sciences (NASDAQ:GILD [https://seekingalpha.com/symbol/GILD]) has reached settlement agreements with Lupin, Cipla, and Laurus Labs to resolve patent disputes related to Biktarvy, a medication fo... Full story

Yahoo Finance • 12 days ago

Immatics appoints industry veteran as CFO

* Immatics N.V. (NASDAQ:IMTX [https://seekingalpha.com/symbol/IMTX]) has appointed Venkat Ramanan as chief financial officer, effective immediately. * Ramanan brings 25+ years of biopharma finance experience, with leadership roles at S... Full story

Yahoo Finance • 12 days ago

Immatics Appoints Venkat Ramanan as Chief Financial Officer

https://immatics.com/ Houston, Texas and Tuebingen, Germany, October 1, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, to... Full story

Yahoo Finance • 13 days ago

What Do Analysts Think About Gilead Sciences (GILD)?

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best large cap value stocks to buy now. On September 22, Morgan Stanley analyst Terence Flynn maintained a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD), keeping the associated price ta... Full story

Yahoo Finance • 13 days ago

Trump seeks more drug pricing deals similar to Pfizer’s

[U.S. President Donald Trump Visits Scotland For Rounds Of Golf And Trade Talks] Christopher Furlong Announcing an agreement with Pfizer (NYSE:PFE [https://seekingalpha.com/symbol/PFE]) to offer all brand-name drugs marketed by the compan... Full story

Yahoo Finance • 14 days ago

Government shutdown looms: SA spotlights 20 defensive dividend stocks in response

[Donkey and Elephant Tug of War for the White House] JimLarkin Congress faces a critical deadline this week as the U.S. government edges closer to a potential shutdown. Lawmakers must reach a funding agreement by 12:01 a.m. Wednesday to a... Full story

Yahoo Finance • 15 days ago

Biogen Inc. (BIIB): A Bull Case Theory

We came across a bullish thesis on Biogen Inc. on Investing With Purpose’s Substack. In this article, we will summarize the bulls’ thesis on BIIB. Biogen Inc.'s share was trading at $143.81 as of September 18th. BIIB’s trailing and forwar... Full story

Yahoo Finance • 17 days ago

Gilead Sciences (GILD) Stock Sees Positive Outlook Amid HIV, Liver, and Cancer Drug Momentum

Gilead Sciences, Inc. (NASDAQ:GILD) ranks among the most undervalued NASDAQ stocks to buy now. Citing momentum in Gilead Sciences, Inc. (NASDAQ:GILD)’s product pipeline, Moody’s updated the company’s outlook from stable to positive on Sept... Full story

Yahoo Finance • 21 days ago

Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors

Pictured: Chris McDonald, newest member of Cellares' Board of Advisors Veteran operations leader, with experience at Amgen, Novartis, AstraZeneca, and Kite/Gilead brings decades of manufacturing, quality, and supply chain expertise to sup... Full story

Yahoo Finance • 21 days ago

Did Gilead's (GILD) $32 Billion AI Bet Just Transform Its Innovation and Global Health Narrative?

Gilead Sciences recently broke ground on a 180,000-square-foot AI-enabled Pharmaceutical Development and Manufacturing Technical Development Center at its Foster City campus, part of a US$32 billion investment plan through 2030, and expand... Full story

Yahoo Finance • 24 days ago

Trump considering website for consumers to buy discounted prescription drugs - report

[Senior man researching about medicine online] blackCAT/E+ via Getty Images * The Trump administration is said to be discussing the launch of a website that would allow consumers to purchase prescription drugs less expensively by buying... Full story

Yahoo Finance • 28 days ago

Alger Russell Innovation Index Updates for Third Quarter 2025

NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the clos... Full story

Yahoo Finance • 28 days ago

Why California’s biopharma boom is critical for logistics

Building Resilience and Innovation: California’s Pharmaceutical Renaissance California is quietly staging a pharmaceutical renaissance, not of arts or culture this time, but of science, supply chains, and life-changing therapies. As the b... Full story

Yahoo Finance • 28 days ago

These S&P500 stocks are gapping in today's session

Curious about the market action on Monday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. [gap] GAP DOWN STOCKS TICKER CHANGE COMMENT CTVA [https://www.chartmill... Full story

Yahoo Finance • 28 days ago

Validea Detailed Fundamental Analysis - GILD

Below is Validea's guru fundamental report for GILEAD SCIENCES, INC. (GILD). Of the 22 guru strategies we follow, GILD rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy lo... Full story

Yahoo Finance • 30 days ago

GILEAD SCIENCES INC (NASDAQ:GILD): A Prime Value Investing Candidate with Strong Fundamentals

In the world of investing, few strategies have shown as much lasting strength as value investing. This method, created by Benjamin Graham and made famous by Warren Buffett, focuses on finding stocks selling for less than their inherent wor... Full story

Yahoo Finance • last month

Notable Friday Option Activity: GSHD, GILD, EOSE

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Goosehead Insurance Inc (Symbol: GSHD), where a total of 2,556 contracts have traded so far, representing approximately 255,600 un... Full story

Yahoo Finance • last month

Dividend Roundup: Meta Platforms, Coca-Cola, UnitedHealth Group, Colgate-Palmolive, and more

[Savings concept - Piggy bank on US nickel coins] PM Images This week's dividend activity included increased payouts from Royal Caribbean Cruises (RCL [https://seekingalpha.com/symbol/RCL]) and Argan (AGX [https://seekingalpha.com/symbol/... Full story